A detailed history of Alamar Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Alamar Capital Management, LLC holds 35,846 shares of DXCM stock, worth $2.88 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
35,846
Holding current value
$2.88 Million
% of portfolio
1.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $2.29 Million - $4.16 Million
35,846 New
35,846 $2.4 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $48,426 - $61,657
439 Added 1.88%
23,848 $2.7 Million
Q4 2023

Mar 06, 2024

BUY
$75.49 - $124.16 $39,330 - $64,687
521 Added 2.28%
23,409 $2.9 Million
Q3 2023

Nov 29, 2023

BUY
$86.06 - $137.93 $184,082 - $295,032
2,139 Added 10.31%
22,888 $2.14 Million
Q2 2023

Aug 24, 2023

BUY
$112.47 - $130.98 $24,068 - $28,029
214 Added 1.04%
20,749 $2.67 Million
Q1 2023

Aug 17, 2023

BUY
$104.0 - $122.92 $3,016 - $3,564
29 Added 0.14%
20,535 $2.39 Million
Q4 2022

Feb 21, 2023

SELL
$84.98 - $122.67 $11,897 - $17,173
-140 Reduced 0.68%
20,506 $2.32 Million
Q3 2022

Nov 18, 2022

SELL
$76.35 - $94.18 $175,757 - $216,802
-2,302 Reduced 10.03%
20,646 $1.66 Million
Q2 2022

Jul 13, 2022

BUY
$67.99 - $132.89 $1.16 Million - $2.26 Million
16,996 Added 285.55%
22,948 $1.71 Million
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $94,174 - $130,330
-1,001 Reduced 14.4%
5,952 $3.05 Million
Q4 2021

Feb 10, 2022

SELL
$129.87 - $162.82 $198,441 - $248,788
-1,528 Reduced 18.02%
6,953 $3.73 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $66,587 - $89,344
624 Added 7.94%
8,481 $4.64 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $27,050 - $36,048
334 Added 4.44%
7,857 $3.36 Million
Q1 2021

May 04, 2021

BUY
$84.79 - $104.74 $67,662 - $83,582
798 Added 11.87%
7,523 $2.7 Million
Q4 2020

Mar 02, 2021

BUY
$78.0 - $104.5 $524,550 - $702,762
6,725 New
6,725 $2.49 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Alamar Capital Management, LLC Portfolio

Follow Alamar Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alamar Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alamar Capital Management, LLC with notifications on news.